PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 49 filers reported holding PROQR THRAPEUTICS N V in Q4 2022. The put-call ratio across all filers is 1.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,711 | -45.8% | 6,701 | -32.5% | 0.00% | – |
| Q2 2023 | $16,082 | +1394.6% | 9,927 | +1865.7% | 0.00% | – |
| Q1 2023 | $1,076 | -86.8% | 505 | -77.1% | 0.00% | – |
| Q4 2022 | $8,158 | -76.0% | 2,205 | +4693.5% | 0.00% | – |
| Q3 2022 | $34,000 | -98.5% | 46 | -98.5% | 0.00% | – |
| Q2 2022 | $2,344,000 | -87.4% | 3,014 | +29.6% | 0.00% | – |
| Q4 2021 | $18,631,000 | +787.2% | 2,326 | +365.2% | 0.00% | – |
| Q4 2020 | $2,100,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Privium Fund Management B.V. | 5,344,446 | $18,010,783 | 6.83% |
| M28 Capital Management LP | 1,910,600 | $7,069,220 | 6.74% |
| Opaleye Management Inc. | 1,460,000 | $5,402,000 | 1.88% |
| Ikarian Capital, LLC | 422,625 | $1,563,713 | 0.38% |
| Monaco Asset Management SAM | 165,000 | $610,500 | 0.18% |
| AWM Investment Company, Inc. | 166,667 | $616,668 | 0.09% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $555 | 0.05% |
| Atom Investors LP | 18,522 | $68,531 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $13,414,228 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 21,514 | $80 | 0.01% |